Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells in Breast Cancer Oncogenesis is a multi-step process leading to a variety of genetic changes with alterations in the transcriptome, and adaptive changes responding to treatments. Therefore, monitoring the dynamic alteration of cancer is critical for cancer treatment. We have integrated multiple microfluidic modules developed in our R21 into a Multi-Phase Single Cell Analyzer (MSCA) for circulating tumor cells (CTC) enumeration and single CTC characterization. Combining the robustness of microstructure, preciseness of optical manipulation and mobility of droplet, the integrated MSCA isolates and encapsulates individual CTC into droplets for nanoliter molecular analysis. With the ability to characterize CTC in routine blood draws, the integrated platform will transform the minimal invasive CTC assessment into a powerful tool for cancer treatment evaluation in hospitals and clinical laboratories, and realize personalized medicine for cancer treatment.
Combining the robustness of microstructure, mobility of droplet and preciseness of optical manipulation, the integrated MSCA can isolate and encapsulate individual CTCs into droplets for nanoliter molecular analysis. The MSCA device holds tremendous potential for new biological insight with very real clinical applications. The integrated platform will transform the minimal invasive CTC assessment into a powerful tool for cancer treatment evaluation in hospitals and clinical laboratories, and realize personalized medicine for cancer treatment.
|Li, Shengwen Calvin; Stucky, Andres; Chen, Xuelian et al. (2018) Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel. Oncotarget 9:33290-33301|
|Jiao, Xuanmao; Velasco-Velázquez, Marco A; Wang, Min et al. (2018) CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion. Cancer Res 78:1657-1671|
|Chen, Xuelian; Wen, Qin; Stucky, Andres et al. (2018) Relapse pathway of glioblastoma revealed by single-cell molecular analysis. Carcinogenesis 39:931-936|
|Zeng, Yunjing; Gao, Li; Luo, Xiaoqing et al. (2018) Microfluidic enrichment of plasma cells improves treatment of multiple myeloma. Mol Oncol 12:1004-1011|
|Chen, Yan; Millstein, Joshua; Liu, Yao et al. (2018) Single-Cell Digital Lysates Generated by Phase-Switch Microfluidic Device Reveal Transcriptome Perturbation of Cell Cycle. ACS Nano 12:4687-4694|
|Stucky, Andres; Chen, Xuelian; Zhong, Jiang F (2018) Gene Manipulation with Micro RNAs at Single-Human Cancer Cell. Methods Mol Biol 1733:215-223|
|Liu, Jun; Zhong, Jiang F; Zhang, Xi et al. (2017) Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies. J Hematol Oncol 10:35|
|Zhang, Cheng; Yang, Shi-Jie; Wen, Qin et al. (2017) Human-derived normal mesenchymal stem/stromal cells in anticancer therapies. J Cancer 8:85-96|
|Li, Shengwen Calvin; Vu, Long T; Luo, Jane Jianying et al. (2017) Tissue Elasticity Bridges Cancer Stem Cells to the Tumor Microenvironment Through microRNAs: Implications for a ""Watch-and-Wait"" Approach to Cancer. Curr Stem Cell Res Ther 12:455-470|
|Chen, Xin; Chakravarty, Tushar; Zhang, Yiqiang et al. (2016) Single-cell transcriptome and epigenomic reprogramming of cardiomyocyte-derived cardiac progenitor cells. Sci Data 3:160079|
Showing the most recent 10 out of 17 publications